FDA Approves New Botox Black Box Warning, Drug Name Changes
The FDA has signed off on a new “black box” warning for Botox and other botulinum toxic drug products, and has approved generic name changes to avoid potential pharmacy errors…
The FDA has signed off on a new “black box” warning for Botox and other botulinum toxic drug products, and has approved generic name changes to avoid potential pharmacy errors…